Stuart Baker

Stuart Baker

Auto-generated profile, based on publicly available information

Stuart Baker

Faculty of Medicine, University of Queensland, QLD, Australia; Department of Intensive Care, Redcliffe Hospital, QLD, Australia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in Anaesthesia and Intensive Care
Verified
Journal Article
Open access
PDF file
PHP. V. Van Heerden
P. V. Van Heerden
SBS. Baker
S. Baker
SLS. I. Lim
S. I. Lim
CWC. Weidman
C. Weidman
MBM. Bulsara
M. Bulsara
The Non-invasive Cardiac Output (NICO) monitor (Novametrix Medical Systems Inc., Wallingford, CT, U.S.A.) utilizes a minimally-invasive partial rebreathing method to determine cardiac output by means of a differential form of the Fick equation. We evaluated the NICO monitor by comparing its output to paired measurements obtained by the standard thermodilution (TD) technique in patients who had recently undergone cardiac surgery. Forty-two paired measurements were carried out in 12 patients. The correlation between the two methods was moderate with a correlation coefficient of 0.691. Repeated measures ANOVA showed that TD measures of cardiac output were significantly higher than those obtained by the NICO monitor (P=0.0003). Comparison of the two techniques using the method described by Bland and Altman showed decreased correlation at higher values of cardiac output. We conclude that the NICO monitor may well have a place in intensive care monitoring, provided patients are not breathing spontaneously and are able to tolerate a 4 mmHg rise in P a co 2 . It is less suitable for use in patients with a high cardiac output state.

1 December 2002 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
NSNorah Spears
Norah Spears
SBStuart Baker
Stuart Baker
VSVlastimil Srsen
Vlastimil Srsen
RLRebecca Lapping
Rebecca Lapping
JMJulie Mullan
Julie Mullan
VAVivian Allison
Vivian Allison
A series of experiments have been carried out to determine whether follicles secrete factors able to affect the growth and development of other, like-sized follicles. Late preantral mouse ovarian follicles were either cocultured or cultured in media conditioned by previously cultured follicles. In particular, the experiments examined whether follicles do secrete such factors, whether the level of FSH in the culture media can affect that process, and what the nature of such secretory factor(s) might be. First, pairs of follicles were cocultured across a polycarbonate membrane containing pores. This showed that communication between the follicles resulted in the stimulation of growth and that the stimulation was due, at least in part, to the production of secretory factor(s). In subsequent experiments, follicles were cultured in media that had been preconditioned by previously cultured follicles. The concentration of FSH in the cultures determined the effect of the conditioned media: conditioned media was stimulatory to follicle growth when levels of FSH remained high throughout the culture, but inhibitory when FSH levels were dropped midway through the cultures. Heat inactivation removed this inhibitory effect, showing that the factor was likely to be a protein; addition of follistatin to the conditioned media did not alter its effect, indicating that the factor was unlikely to be activin. We have shown through a series of culture experiments that mouse follicles secrete factor(s) that can affect the development of other like-sized follicles when cultured from the late preantral to Graafian stages. Furthermore, we have shown that the effect (or production) of such factors is dependent on the FSH environment of the follicles.

1 May 2017 in Anaesthesia and Intensive Care
Verified
Journal Article
Open access
DDDiane Dennis
Diane Dennis
LTL. Torre
L. Torre
SBS. Baker
S. Baker
THT. Hebden-Todd
T. Hebden-Todd
Hyperoxaemia in patients undergoing mechanical ventilation (MV) has been found to be an independent predictor of worse outcome and in-hospital mortality in some conditions. Data suggests that a fraction of inspired oxygen (FiO 2 ) of 0.4 or lower may produce hyperoxaemia although it is commonly accepted without adjustment in ventilator settings. The primary aim of this study was to observe current practice at one Australian tertiary intensive care unit (ICU) with regard to prescription and titration of oxygen (O 2 ) in patients undergoing MV, in particular whether they received higher FiO 2 than required according to arterial blood gas (ABG) results, and whether there was FiO 2 titration as a response to initial ABG results during the 12 hours following. A retrospective observational study of 151 ICU patients undergoing MV between November 2013 and February 2014 was conducted, with ABGs as the primary outcome measure. There were 250 ABG measures, with mean FiO 2 0.38 (range 0.3–1.0) and mean PaO 2 114 mmHg (standard deviation 36). Over all observations, 197 (79%) were of FiO 2 ≤0.4, however no patients were ventilated on room air (FiO 2 0.21) and 114 (46%) were in the hyperoxaemic range. Oxygen titration (up or down) occurred in 31% of patients. Morning ABGs were taken at a time suggested by ICU guidelines, and on review of these measures, the mean FiO 2 was lower than that purported to create toxicity. Subsequently, almost one-third of the cohort had their FiO 2 titrated, however there was a floor effect whereby 39%–43% of the cohort received an FiO 2 of 0.3.

1 March 2007 in Critical Care and Resuscitation
Verified
Journal Article
Open access
ASArthur C. Stephenson
Arthur C. Stephenson
SBStuart Baker
Stuart Baker
NZNikolajs Zeps
Nikolajs Zeps
When potential research participants are incapable of providing consent, it is common for clinicians and researchers to approach family members, attempting to ascertain that person's wishes. Where legally recognised, surrogate consent may also then be provided by relatives for therapy or research involvement. This practice is widely accepted as acknowledging and maintaining patient autonomy, yet there are few data on acceptability of this to the community, or on the accuracy of surrogate decisions. We conducted a questionnaire-based survey of 283 people in the waiting rooms of the emergency and intensive care departments of a tertiary hospital in September 2006 to evaluate attitudes to critical care research, willingness to participate if incapacitated, and acceptability of surrogate consent in these circumstances. 283 people were approached with the questionnaire, with 185 people fully completing and returning them: 17% strongly indicated agreement to research participation if they were critically ill, with 25% indicating they would refuse. Only 26% of respondents thought it acceptable that a relative provide consent to research participation on their behalf. Demographic factors did not influence responses, but views of respondents that participation in research was beneficial to participants correlated with an increased willingness to participate themselves. From our questionnaire, it appears that willingness to participate in research is less than we expected. Surrogate decision-making and the provision of surrogate consent to research was acceptable to only 26% of respondents.


11 August 2025 in Australian Critical Care
Verified
Journal Article
Closed access
DFDylan F. Flaws
Dylan F. Flaws
SBStuart Baker
Stuart Baker
ABAdrian Barnett
Adrian Barnett
KJKylie Jacobs
Kylie Jacobs
OMOlivia Metcalf
Olivia Metcalf
TVTracey Varker
Tracey Varker